Industry

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for immune reset Candid’s lead asset, cizutamig, a bispecific antibody directed to B-cell maturation antigen (BCMA) on plasma cells and CD3 on T-cells, is currently in multiple phase 1 clinical studies across various autoimmune diseases Total … [Read more…]

The Milken Institute convenes its 29th annual Global Conference in Los Angeles, May 3–6 LOS ANGELES–(BUSINESS WIRE)–The Milken Institute’s 29th annual Global Conference opens today, May 3, 2026, and runs through May 6, 2026, at The Beverly Hilton and Waldorf Astoria Beverly Hills in Los Angeles. Held under the theme Leading in a New Era, … [Read more…]

The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology. Then bring your family. SALT LAKE CITY–(BUSINESS WIRE)–NomosLogic, Inc., the molecular medicine infrastructure company, today launched two new consumer experiences on Dendrite Lite, available now … [Read more…]

CHICAGO–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were presented at the 106th American Association for Thoracic Surgery Annual Meeting. As evidence increasingly supports treating patients earlier in the valve disease pathway, the need for … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–#coffee–Laird Superfood, Inc. (NYSE American: LSF) will report financial results for the first quarter ended March 31, 2026 on Thursday, May 14, 2026 after market close. Management will host a webcast at 5:00 p.m. ET on the same day to discuss the results. Participants may access the live webcast on the Laird Superfood … [Read more…]

Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi® (ruxolitinib) Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily Jakafi Jakafi XR will be available for pharmacy orders by May 8 WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) … [Read more…]

PHOENIX–(BUSINESS WIRE)–Outfront Health, a provider of physician-guided preventive health screenings, today announced the appointment of Dr. Shane Speirs, MD, MBA, as Chief Medical Officer (CMO). In this role, Dr. Speirs will lead clinical strategy, oversee screening protocols, and support the company’s expansion of non-invasive cardiovascular and stroke risk screening services. Dr. Speirs brings extensive experience … [Read more…]

RestorixHealth joins industry leaders to commemorate the history, innovation and healing benefits of hyperbaric medicine. METAIRIE, La.–(BUSINESS WIRE)–#WhereHealingHappens–RestorixHealth, the nation’s premier partner for wound care and hyperbaric center management, is pleased to join the broader hyperbaric medicine community in recognizing May as Hyperbaric Awareness Month. Launched in 2021 by the Undersea & Hyperbaric Medical Society, … [Read more…]

NEW YORK–(BUSINESS WIRE)–Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of Noramco, Extractas Biosciences, and Purisys of the Noramco Group (“Noramco” or the “Company”) to Siegfried Holding AG (SIX: SFZN; “Siegfried”), … [Read more…]

ALL-REMOTE COMPANY/WILMINGTON, Del.–(BUSINESS WIRE)–Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2027 financial results after the close of market trading on Wednesday, May 27, 2026. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on … [Read more…]